Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | VRN101099 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
VRN101099 is a blood-brain barrier penetrant covalent inhibitor of ERBB2 (HER2), which decreases Erbb2 (Her2), Akt, and Erk phosphorylation and potentially inhibits tumor cell proliferation and tumor growth (Cancer Res (2023) 83 (5_Supplement): P1-11-03). |
| DrugClasses | HER2 Inhibitor 44 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| VRN101099 | VRN101099 | 0 | 1 |